首页> 外文期刊>Contrast media & molecular imaging >Surgical tissue handling methods to optimize ex vivo fluorescence with the activatable optical probe ?3a??glutamyl hydroxymethyl rhodamine green
【24h】

Surgical tissue handling methods to optimize ex vivo fluorescence with the activatable optical probe ?3a??glutamyl hydroxymethyl rhodamine green

机译:用可激活的光学探针α3aβ-谷氨酰羟甲基罗丹明绿优化体外荧光的外科组织处理方法

获取原文
           

摘要

Optical fluorescence imaging has been developed as an aid to intraoperative diagnosis to improve surgical and endoscopic procedures. Compared with other intraoperative imaging methods, it is lower in cost, has a high safety margin, is portable and easy to use. ?3a??glutamyl hydroxymethyl rhodamine green (gGlua??HMRG) is a recently developed activatable fluorescence probe that emits strong fluorescence in the presence of the enzyme ?3a??glutamyl transpeptidase (GGT), which is overexpressed in many cancers, including ovarian cancer. Ex vivo testing is important for clinical approval of such probes. The diagnostic performance of gGlua??HMRG in fresh excised surgical specimens has been reported; however, details of tissue handling have not been optimized. In this study, we investigated four different tissue handling procedures to optimize imaging in excised tumor specimens. The fluorescence intensity time courses after the different tissue handling methods were compared. Additionally, the fluorescence positive areas were correlated with the presence of red fluorescent protein (RFP) in an RFP positive cell line as the standard of reference for cancer location. In the a??intacta?? groups, tumors yielded quick and homogeneous activation of gGlua??HMRG. In the a??rinsea?? and a??cuta?? groups, the fluorescence intensity of the tumor was a little lower than that in the intact group. In the a??presseda?? groups, however, fluorescence intensity from gGlua??HMRG was lower over the entire time course, suggesting a decrease or relocation of excreted GGT. In conclusion, we demonstrate that the method of tissue handling prior to ex vivo imaging with the activatable probe gGlua??HMRG has a strong influence on the signal derived from the specimen. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
机译:已经开发了光学荧光成像以辅助术中诊断以改善手术和内窥镜检查程序。与其他术中成像方法相比,它成本较低,安全系数高,便于携带且易于使用。 α3aβ谷氨酰羟甲基罗丹明绿(gGluaβHMRG)是最近开发的一种可激活的荧光探针,在存在β3aβ谷氨酰转肽酶(GGT)的酶存在下会发出强烈的荧光,该酶在包括卵巢癌在内的许多癌症中都过表达。癌症。离体测试对于此类探针的临床批准很重要。已经报道了gGluaΔHMRG在新鲜切除的手术标本中的诊断性能。但是,组织处理的细节尚未优化。在这项研究中,我们调查了四种不同的组织处理程序,以优化切除的肿瘤标本中的成像。比较了不同组织处理方法后的荧光强度时间进程。此外,荧光阳性区域与RFP阳性细胞系中红色荧光蛋白(RFP)的存在相关,作为癌症定位的参考标准。在一个?intacta?各组中,肿瘤产生了gGluaΔHMRG的快速且均匀的活化。在a?rinsea ??还有一个?肿瘤的荧光强度略低于完整组。在一个?但是,在整个时间过程中,来自gGluaΔHMRG的荧光强度较低,这表明排泄的GGT减少或重新定位。总之,我们证明了用可活化探针gGluaΔHMRG进行离体成像之前的组织处理方法对源自标本的信号有很大的影响。 2016年发布。本文是美国政府的工作,在美国属于公共领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号